Detalhe da pesquisa
1.
BACE2 beyond ß-processing of APP, its neuroprotective role in cerebrovascular endothelium.
J Neurochem;
166(6): 887-890, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37587672
2.
No evidence for cognitive decline or neurodegeneration in strain-matched Grin3a knockout mice.
Alzheimers Dement;
19(9): 4264-4266, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37483152
3.
Presenilin 1 Modulates Acetylcholinesterase Trafficking and Maturation.
Int J Mol Sci;
24(2)2023 Jan 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36674948
4.
ADAM10 Gene Variants in AD Patients and Their Relationship to CSF Protein Levels.
Int J Mol Sci;
24(7)2023 Mar 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37047093
5.
Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
Int J Mol Sci;
24(3)2023 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36769057
6.
Plasma ACE2 species are differentially altered in COVID-19 patients.
FASEB J;
35(8): e21745, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34191346
7.
Altered Balance of Reelin Proteolytic Fragments in the Cerebrospinal Fluid of Alzheimer's Disease Patients.
Int J Mol Sci;
23(14)2022 Jul 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35886870
8.
Tau phosphorylation by glycogen synthase kinase 3ß modulates enzyme acetylcholinesterase expression.
J Neurochem;
157(6): 2091-2105, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32955735
9.
Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer's Disease.
Medicina (Kaunas);
57(9)2021 Sep 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34577877
10.
Measurement of CSF α-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer's disease.
J Neurochem;
150(2): 218-230, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31077373
11.
Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis.
Neurobiol Dis;
124: 428-438, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30594809
12.
Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease.
FASEB J;
32(7): 3536-3546, 2018 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29442527
13.
Levels of ADAM10 are reduced in Alzheimer's disease CSF.
J Neuroinflammation;
15(1): 213, 2018 Jul 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30045733
14.
ApoER2 processing by presenilin-1 modulates reelin expression.
FASEB J;
28(4): 1543-54, 2014 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24344333
15.
Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease.
Front Neurol;
14: 1124145, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37292130
16.
Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy.
Front Immunol;
13: 1001951, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36311758
17.
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients.
Alzheimers Res Ther;
14(1): 161, 2022 11 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36324176
18.
The apolipoprotein receptor LRP3 compromises APP levels.
Alzheimers Res Ther;
13(1): 181, 2021 11 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34727970
19.
Increased P2×2 receptors induced by amyloid-ß peptide participates in the neurotoxicity in alzheimer's disease.
Biomed Pharmacother;
142: 111968, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34343896
20.
Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
Neurobiol Dis;
37(3): 682-91, 2010 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20025970